Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/02/120   
Active ingredient: Duramycin
Indication: Treatment of cystic fibrosis
Sponsor: AOP Orphan Pharmaceuticals AG
Wilhelminenstraβe 91/IIf/B4, A-1160 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2002 Orphan designation EMEA/OD/038/02 (2002)4518 of 13/11/2002
22/12/2004 Transfer of orphan designation EMEA/OD/038/02/T/01 (2004)5107 of 21/12/2004